Don Benjamin
Impact in
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Metabolism, Diabetes, and Cancer
- RNA Research and Splicing
- Mitochondrial Function and Pathology
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 5
- Metabolism, Diabetes, and Cancer 3
- RNA Research and Splicing 3
- Epigenetics and DNA Methylation 2
- Enzyme function and inhibition 2
- Genomics and Chromatin Dynamics 2
-
- Cancer, Hypoxia, and Metabolism 3
- Co-authors
- Michael N. Hall (8 shared papers)Christoph Moroni (7 shared papers)Marco Colombi (4 shared papers)Timm Maier (1 shared paper)Sravanth K. Hindupur (2 shared papers)Heidi A. Lane (2 shared papers)Mahmoud El‐Shemerly (2 shared papers)Dimitri Robay (1 shared paper)
- Journals
- Cell Reports (2 papers)European Journal of Human Genetics (1 paper)Nature Cell Biology (1 paper)Molecular BioSystems (1 paper)Oncogene (1 paper)
- Partner nations
- SwitzerlandUnited StatesUnited Kingdom
In The Last Decade
Don Benjamin
14 papers receiving 1.8k citations
Don Benjamin's Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 337
- Molecular Biology 1.2k
- Aging 24
- Physiology 49
- Immunology 196
Countries citing papers authored by Don Benjamin
This map shows the geographic impact of Don Benjamin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Benjamin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Benjamin more than expected).
Fields of papers citing papers by Don Benjamin
This network shows the impact of papers produced by Don Benjamin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Benjamin. The network helps show where Don Benjamin may publish in the future.
Co-authors
The 25 scholars most cited alongside Don Benjamin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Rapamycin passes the torch: a new generation of mTOR inhibitors Hit paper breakdown → | 2011 | 812 |
| 2 | 2018 | 297 | |
| 3 | mTOR substrate phosphorylation in growth control Hit paper breakdown → | 2022 | 293 |
| 4 | 2006 | 78 | |
| 5 | 2016 | 67 | |
| 6 | 2001 | 65 | |
| 7 | 2007 | 55 | |
| 8 | 2010 | 39 | |
| 9 | 2000 | 28 | |
| 10 | 1999 | 17 | |
| 11 | 2013 | 14 | |
| 12 | 2022 | 13 | |
| 13 | 2006 | 8 | |
| 14 | 2017 | 4 |
About Don Benjamin
Don Benjamin is a scholar working on Molecular Biology, Cancer Research, Surgery, Oncology and Genetics, having authored 14 papers that have together received 1.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer, Hypoxia, and Metabolism (3 papers), Metabolism, Diabetes, and Cancer (3 papers), RNA Research and Splicing (3 papers), Epigenetics and DNA Methylation (2 papers), Enzyme function and inhibition (2 papers), Cancer-related Molecular Pathways (2 papers) and Genomics and Chromatin Dynamics (2 papers). The work is most often cited by research in Cancer Research (337 citations), Molecular Biology (1.2k citations), Aging (24 citations), Physiology (49 citations) and Immunology (196 citations). Don Benjamin has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Michael N. Hall, Christoph Moroni, Marco Colombi, Timm Maier, Sravanth K. Hindupur, Heidi A. Lane, Mahmoud El‐Shemerly, Dimitri Robay, Jens Pohlmann and Sauveur-Michel Maira. Their work appears in journals such as Cell Reports, European Journal of Human Genetics, Nature Cell Biology, Molecular BioSystems and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.